NCT01949545 Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Advanced Malignancies and Hepatic Impairment Status COMPLETED Phase PHASE1
NCT01945710 An Open-label, Multicenter, Multiple Dose, Phase 1 Study to Establish the Maximum Tolerated Dose of E7389 Liposomal Formulation in Patients With Solid Tumors Status COMPLETED Phase PHASE1
NCT01943461 Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor JPN) Status COMPLETED Phase PHASE1
NCT01940601 Pharmacodynamics, Pharmacokinetics, Efficacy and Safety of Balugrastim in Pediatric Patients With Solid Tumors Status WITHDRAWN Phase PHASE2
NCT01930292 Debio 1143 in Combination With Carboplatin and Paclitaxel in Patient With Advanced Solid Malignancies Status TERMINATED Phase PHASE1
NCT01922752 To Determine the Maximum Tolerated Dose of Oral CEP-37440 in Patients With Advanced or Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT01905228 A Phase 1 Trial of CBL0137 in Patients With Metastatic or Unresectable Advanced Solid Neoplasm Status COMPLETED Phase PHASE1
NCT01878890 Phase I Dose Escalation Trial of Efavirenz in Solid Tumours or Non-Hodgkin Lymphoma in Therapeutic Failure. Status COMPLETED Phase PHASE1
NCT01877811 Study of RXDX-105, Potent RET Inhibitor in Patients With Advanced Lung Cancer and Other Solid Tumors Status COMPLETED Phase PHASE1
NCT01875601 NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01862328 Dose Escalation, Multi-arm Study of MLN4924 Plus Docetaxel, Gemcitabine, or Combination of Carboplatin and Paclitaxel in Participants With Solid Tumors Status COMPLETED Phase PHASE1
NCT01858883 Safety Study of Itacitinib (INCB039110) in Combination With Gemcitabine and Nab-Paclitaxel in Subjects With Advanced Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT01851369 TRC102 and Temozolomide for Relapsed Solid Tumors and Lymphomas Status COMPLETED Phase PHASE1/PHASE2
NCT01844869 An Open-Label Study to Investigate the Pharmacokinetics of Omacetaxine Mepesuccinate Status COMPLETED Phase PHASE1
NCT01844661 Safety and Efficacy of Repeated Infusion of CELYVIR in Children and Adults With Metastatic and Refractory Tumors. Status COMPLETED Phase PHASE1/PHASE2
NCT01844583 Safety, Tolerability and Pharmacokinetic (PK) of Concomitant Esomeprazole and Rifampin, and QT Study on Single and Multiple-doses of Alisertib Status COMPLETED Phase PHASE1
NCT01832506 A Japanese Phase 1 Trial of c-Met Inhibitor MSC2156119J in Subjects With Solid Tumors Status COMPLETED Phase PHASE1